Distinguished in Scleroderma

Dr. Stephen M. Lindsey

Rheumatology
Louisiana State University School Of Medicine In New Orleans Faculty G
2000 Canal St, 
New Orleans, LA 
Accepting New Patients
Distinguished in Scleroderma
Louisiana State University School Of Medicine In New Orleans Faculty G
2000 Canal St, 
New Orleans, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Stephen Lindsey is a Rheumatologist in New Orleans, Louisiana. Dr. Lindsey is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Rheumatoid Arthritis (RA), Lupus Nephritis, Scleroderma, and Systemic Sclerosis (SSc). Dr. Lindsey is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in LA
Hospital Affiliations
University Medical Center New Orleans
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Magnolia Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS FACULTY G
2000 Canal St, New Orleans, LA 70112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: July 17, 2025
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
View 4 Less Clinical Trials

4 Total Publications

The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
Journal: Annals of internal medicine
Published: September 27, 2021
Similar Doctors
Lesley A. Saketkoo
Elite in Scleroderma
Dr. Lesley A. Saketkoo
Rheumatology | Pediatrics
Elite in Scleroderma
Dr. Lesley A. Saketkoo
Rheumatology | Pediatrics

University Medical Center New Orleans

1542 Tulane Ave, 
New Orleans, LA 
 (0.4 miles away)
504-702-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lesley Saketkoo is a Rheumatologist and a Pediatrics provider in New Orleans, LA. Dr. Saketkoo is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Sarcoidosis, Scleroderma, Systemic Sclerosis (SSc), and Pulmonary Hypertension. Dr. Saketkoo is currently accepting new patients.

Distinguished in Scleroderma
Dr. Robert J. Quinet
Rheumatology
Distinguished in Scleroderma
Dr. Robert J. Quinet
Rheumatology

Ochsner Clinic LLC

1514 Jefferson Hwy, 
New Orleans, LA 
 (3.9 miles away)
504-842-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Quinet is a Rheumatologist in New Orleans, Louisiana. Dr. Quinet is rated as a Distinguished provider by MediFind in the treatment of Scleroderma. His top areas of expertise are Rheumatoid Arthritis (RA), Scleroderma, Systemic Sclerosis (SSc), and Scleroma. Dr. Quinet is currently accepting new patients.

Advanced in Scleroderma
Dr. Chandana B. Keshavamurthy
Rheumatology
Advanced in Scleroderma
Dr. Chandana B. Keshavamurthy
Rheumatology

Physician, Southshore Region

1514 Jefferson Hwy, 
New Orleans, LA 
 (3.9 miles away)
504-842-3920
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Chandana Keshavamurthy is a Rheumatologist in New Orleans, Louisiana. Dr. Keshavamurthy is rated as an Advanced provider by MediFind in the treatment of Scleroderma. Her top areas of expertise are Rheumatoid Arthritis (RA), Scleroderma, Lupus Nephritis, and Scleroma. Dr. Keshavamurthy is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lindsey's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile